Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

BACKGROUND: The clinical course of cutaneous melanoma (CM) can differ significantly for patients with identical stages of disease, defined clinico-pathologically, and no molecular markers differentiate patients with such a diverse prognosis. This study aimed to define the prognostic value of whole g...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Sonego, Paolo, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539917/
https://www.ncbi.nlm.nih.gov/pubmed/22950745
http://dx.doi.org/10.1186/1479-5876-10-185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539917/
https://www.ncbi.nlm.nih.gov/pubmed/22950745
http://dx.doi.org/10.1186/1479-5876-10-185

Ejemplares similares